Abstract
The future of biomedical research. In this capacity, EMMA plays a vital role in addressing major challenges in biomedical research, such as resource quality, enhancing reproducibility, and promoting ethical animal use. By cryopreserving genetically modified strains, repositories, such as EMMA, reduce the need for continuous live breeding, aligning with the 3Rs principle-Replace, Reduce, Refine-mandated by EU Directive 2010/63/EU (Russell and Burch 1992; Lloyd et al. 2015; Allen et al. 2023) yet not compromising the reproducibility of research
Funding Information
  • European Commission (101131669)
  • UKRI Medical Research Council (MC_UP_2201/2)
  • Italian Ministry of University and Research
  • ΙnfrafrontierGR / Phenotypos (MIS 5002135)
  • University of Oulu, Biocenter Finland, and Research Council of Finland (367712)
  • Agence Nationale de la Recherche (ANR-10-INBS-07 PHENOMIN)
  • CSIC support for large European infrastructures (INFRA23012)
  • INBS PHENOMIN (ANR-10-INBS-07)
  • IdEx Unistra (ANR-10-IDEX-0002)
  • Czech Academy of Sciences (RVO 68378050)
  • Ministry of Education, Youth and Sports (LM202303, LM2018126, LM202303 , LM2018126)
  • Ministry of Education, Youth and Sports (MEYS); European Structural and Investing Funds (CZ.02.1.01/0.0/0.0/16_013/0001789)

This publication has 21 references indexed in Scilit: